期刊
IMMUNOLOGY LETTERS
卷 121, 期 1, 页码 22-26出版社
ELSEVIER
DOI: 10.1016/j.imlet.2008.07.013
关键词
CCL20; Mononuclear cells and serum amyloid A (SAA)
类别
资金
- Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Brazil)
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Brazil)
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Brazil)
Although the serum levels of SAA had been reported to be upregulated during inflammatory/infectious process, the role of this acute-phase protein has not been completely elucidated. In previous studies, we demonstrated that SAA stimulated the production of TNF-alpha, IL-1 beta, IL-8, NO, and ROS by neutrophils and/or mononuclear cells. Herein we demonstrate that SAA induces the expression and release of CCL20 from Cultured human blood mononuclear cells. We also focus on the signaling pathways triggered by SAA. in THP-1 cells SAA promotes phosphorylation of p38 and ERK1/2. Furthermore, the addition of SB203580 (p38 inhibitor) and PD98059 (ERK 1/2 inhibitor) inhibits the expression and release of CCL20 in mononuclear cells treated with SAA. Our results point to SAA as an important link of innate to adaptive immunity, once it might act on the recruitment of mononuclear cells. (C) 2008 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据